webinar
How to master both Marketing Authorization and Joint Clinical Assessment successfully?
The European Union is transforming its health technology assessment process with the introduction of the Joint Clinical Assessment (JCA) under…
webinar
Getting an Early Access Program Off the Ground Safely
Embracing an Early Access Program (EAP) presents a strategic avenue for creating valuable opportunities for patients and companies. This webinar…
Case study
Innovative Marketing Authorization Transfer Preserves Vital Patient Supply
The marketing authorization is a key step in the product development pipeline of any healthtech product. It involves the assessment…
Case study
Early Asset Strategic Positioning Enhances Product Development Plan
A French based research company was looking for a proper guidance on positioning their main asset and estimate the market…
webinar
Patient Engagement Explained: Insights from a Patient, a Patient Association and a Pharmaceutical Company
Have you wondered about the role of patient engagement in healthcare product development? Currently, there is a huge emphasis on…
blog
Social Security Finance Bill 2021 in France: Reform on early access to health technologies What…
The PLFSS 2021 law was voted but all decrees are not yet published. Ongoing discussions with the CEPS (Pricing Committee)…
publication
Advanced therapies in the EU: challenges with HTA and real-world evidence
Market access aims to make a health technology not only available and affordable for every patient, but also profitable for…
